Balaji Amines Limited — Updates, 29-05-2025: Press Release

Balaji Amines has announced a board meeting on the financial results for the quarter and half-year. Q4 consolidated revenue was ₹361 Cr, with EBITDA at ₹68 Cr and PAT at ₹40 Cr, showing sequential volume and margin improvement but lower than last year. The company remains zero-debt on a standalone basis. Key expansions include an 8 MW solar plant and new plants for Electronic Grade DMC and Propylene Glycol Pharma Grade. Projects like Dimethyl Ether and N-Methyl Morpholine are ongoing, while a ₹750 Cr greenfield project in the subsidiary is progressing on schedule.